20 employees
Magellan Biosciences is provider of point-of-care analyzers and automated systems for hospital-based labs and near-patient testing.
1968
$50M
from 4 investors over 4 rounds
ESA Biosciences raised $50M on November 29, 2006
Investors: Nexus Medical Partners/Bison Capital, Abingworth, Ampersand Capital Partners and BlueHub Capital